France

BMI View: Non-healthcare companies will increasingly enter the medical services sector. Companies see medical services as a sustainable and expanding business, principally because people... 2012-10-18

BMI View: Despite Sanofi's decision to scale back job cuts in France, we believe the restructuring announcement by themultinational drugmaker, in addition to other... 2012-10-05

BMI View: The continuation of falling revenue from generic competition to Taxotere (docetaxel), Lovenox (enoxaparin) and Ambien (zolpidem) and the lower sales expectation for Plavix... 2012-07-30

BMI View: The French drug market will experience a decline over the 2011-2016 forecast period. Our bearish outlook takes into account the challenging state of the economy, the government's... 2012-07-03

BMI View: France's high public debt-to-GDP ratio will necessitate more aggressive fiscal tightening by the state, including targeting the pharmaceuticals and healthcare sector, which... 2012-06-19

BMI View: The drug markets of the EU5 countries, Germany, the UK, France, Spain and Italy, will experience a decline over the 2011-2016 forecast period. Our bearish outlook takes into... 2012-06-11

BMI View: Dialogue between firms, regulators and payers will become more common as the communication of product value becomes increasingly important. Regulatory agencies that make reimbursement... 2012-05-18